CoChat

GLP‐1 analogue prevents NAFLD in ApoE KO mice with diet and Acrp30 knockdown by inhibiting c‐JNK

Zhang, Lili, Yang, Mengliu, Ren, Hong, Hu, Huaidong, Boden, Guenther, Li, Ling, Yang, Gangyi · 2013 · Liver International
Cited by 65

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Background & Aims: Liraglutide, a Glucagon‐like peptide‐1(GLP‐1) analogue with 97% sequence identity to human GLP‐1, increases insulin secretion and insulin sensitivity. Its effect on non‐alcoholic fatty liver disease (NAFLD) remains poorly understood. In this study, we examined whether liraglutide can protect against inflammatory stress by inhibiting activation of c‐Jun N‐terminal protein kinase (JNK). Methods: ApoE KO and adiponectin (Acrp30) knockdown mice fed a high‐fat diet (HFD) were treated with liraglutide (1 mg/kg, twice daily) for 8 weeks. Liver tissue was procured for histological examination, real‐time RT‐PCR and Western blot analysis. Results: The results showed that the combination of HFD, Acrp30 knockdown and ApoE deficiency had additive effects on the development of insulin resistance (IR) and NAFLD. Administration of liraglutide prevented the development of HFD and hypoadiponectinaemia–induced IR and NAFLD in this model. Liraglutide also attenuated the expression of proinflammatory cytokines or transcription factor, including TNF‐α and NF‐κB 65, and the expression of two lipogenesis‐related genes, Acetyl‐CoA Carboxylase (ACC) and fatty acid synthase (FAS). These changes were accompanied by elevated plasma of Acrp30, increased Acrp30 mRNA, AMP Kinase phosphorylation, and decreased mitogen‐activated protein kinase 4 (MKK4) mRNA expression and JNK phosphorylation. Conclusions: Our study also showed potent inhibitory effects of liraglutide on MKK 4/JNK signalling which may be a mechanism for the observed improved insulin sensitivity and inflammatory stress induced by HFD and hypoadiponectinaemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/liv.12120

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 13

  1. 10.1056/NEJMra011775 · DOI · Paper page
  2. 10.1002/hep.20973 · DOI · Paper page
  3. 10.1136/gut.48.2.206 · DOI · Paper page
  4. 10.1126/science.1071924 · DOI · Paper page
  5. 10.1002/hep.23929 · DOI
  6. 10.1016/j.jhep.2010.09.032 · DOI · Paper page
  7. 10.1210/en.2009-1166 · DOI · Paper page
  8. 10.1016/j.cyto.2008.10.006 · DOI
  9. 10.2337/diabetes.50.2.315 · DOI · Paper page
  10. 10.1007/BF03346561 · DOI
  11. 10.1055/s-2004-826172 · DOI · Paper page
  12. 10.1016/j.tem.2010.08.010 · DOI · Paper page
  13. 10.1016/S0959-437X(01)00258-1 · DOI · Paper page

Cited by

See all 65

Metadata

Authors
Zhang, L., Yang, M., Ren, H., Hu, H., Boden, G., Li, L., & Yang, G.
Venue
Liver International
Publisher
Wiley
Published
2013-02-24
Volume
33
Issue
5
Pages
794-804
ISSN
  • 0106-9543 (ISSN-L)
  • 1478-3223
  • 1478-3231
OpenAlex
W2079094133
Cited by
65
References
10
FWCI
4.76
Type
journal article
Language
en
Open access
closed
Funders
  • National Natural Science Foundation of China (30871199, 81070640, 30971388 and 30771037)
  • Doctoral Fund of Ministry of Education of China (20105503110002)
  • Natural Science Foundation Key Project of CQ cstc (cstc2012 jjB10008)
  • Special Foundation for Postdoctoral Project of CQ (Yu xm201103004)
  • the American Diabetes Association grant (1-10-CT-06)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: GLP‐1 analogue prevents NAFLD in ApoE KO mice with diet and Acrp30 knockdown by inhibiting c‐JNK. https://app.cochat.ai/papers/10.1111/liv.12120
The paper
Zhang, L., Yang, M., Ren, H., Hu, H., Boden, G., Li, L., & Yang, G. (2013). GLP‐1 analogue prevents NAFLD in ApoE KO mice with diet and Acrp30 knockdown by inhibiting c‐JNK. Liver International. https://doi.org/10.1111/liv.12120

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.